Clinical studies indicate that alcohol dependence has an additive effect on cognitive deficits associated with HIV-1 infection. Findings in humans and animal models suggest that alcohol, similar to HIV-1, induces inflammatory processes in the brain leading to neurodegeneration. The causes of HIV-1-associated neurotoxicity are comparable to those mediating alcohol-induced neuronal injury. This review aims to present the mechanisms of the combined effects of HIV-1 and alcohol abuse in the brain and to discuss neuroprotective therapies. Oxidative stress, overproduction of pro-inflammatory factors, impairment of blood-brain barrier and glutamate associated neurotoxicity appear to play important roles in alcohol driven neurodegeneration. Diminution of neuroinflammation constitutes a logical approach for prevention of HIV-1 and alcohol mediated neurodegeneration. Agonists of cannabinoid receptor 2 (CB 2 ) possess potent anti-inflammatory and neuroprotective properties. We address multifaceted beneficial effects of CB 2 activation in the setting of HIV-1 brain infection and alcohol abuse.
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Introduction
The clinical and neuropsychological complex of HIV-1 associated dementia (HAD) is usually described as a frontal-subcortical pattern of impairment. The following cognitive areas demonstrate deterioration: fine motor coordination and speed, sustained attention, processing speed, executive function, learning efficiency and working memory (Grant et al., 1995) . Three forms of HAD have been described, including (1) frank HAD, characterized by severe impairment in two or more cognitive areas with marked impact on everyday function; (2) mild neurocognitive disorder with impairment in two or more cognitive functions that produces modest interference with everyday functioning (equivalent to minor cognitive motor disorder, MCMD); and (3) asymptomatic neurocognitive impairment, documented by impairment in two or more ability areas without apparent effect on everyday functioning.
One quarter of adults and 50% of children used to develop significant neurocognitive complications as a consequence of infection at a period of immunosuppression or AIDS before the introduction of anti-retroviral therapy (ART) (Navia et al., 1986) . While subclinical metabolic and structural abnormalities are detectable in neurologically asymptomatic subjects, overt HAD usually develops as a late complication and is accompanied by immunosuppression (Koralnik et al., 1990) .
Introduction of ART considerably changed the clinical evolution of HIV-1 infection (Palella et al., 1998) . ART diminished the incidence and prevalence of major opportunistic infections and resulted in improvement in survival rates. Patients (10-15%) are now over 50 years of age and, with continued advances in treatment, many will reach normal life expectancy (Navia and Rostasy, 2005) . Markedly improved survival rates brought to light other factors not previously considered to any great extent, including the effects of aging, chronic infection and the neurotoxic effects of ART itself. Indeed, nucleoside reverse transcriptase inhibitors (NRTIs) suppress HIV-1 replication, but they are associated with mitochondrial toxicity (Schweinsburg et al., 2005) . Reduction of the neuronal marker, N-acetylaspartate, in frontal lobe white and gray matter was found in individuals taking NRTIs, didanosine and/or 0889-1591/$ -see front matter Ó 2011 Elsevier Inc. All rights reserved. doi:10.1016/j.bbi.2011.03.001
